Enterome, a gut healthcare company backed by Natixis venture unit Seventure, raises the funds after a $1.5m seed round from Inra Transfert, the French National Institute in Agronomic Research's tech transfer organisation.
Enterome, a company focused on diseases of the gut, has raised €5m ($6.6m).
The company’s series A was co-led by Seventure, part of France-based bank Natixis, and venture firm Lundbeckfond Ventures.
It previously raised €1.5m from Seventure Partners and Inra Transfert, the French National Institute in Agronomic Research’s tech transfer organisation.
Gérard Jacquin, president of Inra Technology Transfer organisation, said: "We are particularly pleased to see one of our main research assets being translated into a company and financed by…
